NIH Studies: Pulmonary/Respiratory Diseases

Below is a listing of government-funded clinical trials in Pulmonary/Respiratory Diseases, being conducted by the various National Institutes of Health at the Warren Grant Magnuson Clinical Center in Bethesda, MD.

Click on a study summary to view the study description and contact information directly from the NIH's web site.

Long-Term, Open-Label, Multicenter, Extension Study of Bosentan in Patients with Pulmonary Hypertension Associated with Sickle Cell Disease Completing a Double-Blind ASSET Study (AC-052-368 or AC 052-369)

Classification of Fetal Breathing Patterns in the Maturing Upper Airway: Spectral Waveform Analysis of Amniotic Fluid Flow Dynamics in Normal Development, Polyhydramnios, and Oligohydramnios

Cardiopulmonary Function Assessment and NO Based Therapies for Patients with Hemolysis-Associated Pulmonary Hypertension

The Effect of a Systemic Oral Care Program on Reducing Exposure to Oropharyngeal Pathogens in Critically III Patients

Role of Helicobacter Pylori and Its Toxins in Pulmonary and Oropharyngeal Disease

Specimen Procurement From Individuals With Hereditary Pulmonary Fibrosis

Clinical Course in Cystic Fibrosis: The Effects of Pseudomonas Aeruginosa and Potential Modifier Genes

Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders with Alemtuzumab (Campath)

Safety of WT1 and PR1 Peptide Vaccination for Patients with MDS

Comprehensive Evaluation of the Etiology and Pathogenesis of Chronic Lung Disease

Exhaled Breath Condensate as a Measurement of Airway Inflammation in Children with Asthma

Diagnosis and Treatment of Patients with Cystic Fibrosis and Other Disorders of the Respiratory System or Pancreas

Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage from Patients with Lung Infiltrates

Pulmonary Fibrosis with Rheumatoid Arthritis: Definition of the Natural History of Disease

Evaluation and Management of Persons with Severe Acute Respiratory Syndrome (SARS)

The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers

Pulmonary Fibrosis Associated with Rheumatoid Arthritis: Identification of Genetic Polymorphisms

Evaluation of Synergy of Combining Hydroxyurea with Recombinant Human Erythropoietin Glycoform Alpha (rhu Erythropoietin-alpha) on Fetal Hemoglobin Synthesis in Patients with Sickle Cell Anemia

Atorvastatin as a Disease Modifying Agent in Stage II and III Pulmonary Sarcoidosis: A Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Octreotide in Patients with Lymphangioleiomyomatosis

A Study of Adjuvant Cytokine Therapy in Pulmonary Mycobacterium Avium Complex Infection

Mechanism and Vascular Effects of Endothelial Progenitor Cell Mobilization in Patients with Coronary Artery Disease Undergoing Cardiac Rehabilitation

Tissue Collection Protocol for Individuals with Cystic Fibrosis

Inhaled Nitric Oxide Therapy for Patients with Sickle Cell Anemia and Secondary Pulmonary Hypertension

Fiberoptic Bronchoscopy in Patients with Asthma

Evaluation and Treatment of Pulmonary Patients not Participating in Research (Training Protocol)

Effect of Hyperoxia on Oxidation of Proteins and Nucleic Acids in Human Volunteers

Role of Genetic Factors in the Pathogenesis of Lung Disease

Segmental Bronchoalveolar Lavage

Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients with Symptomatic Pulmonary Hypertension Associated with Sickle Cell Disease (ASSET 2)

Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients with Symptomatic Pulmonary Arterial Hypertension Associated with Sickle Cell Disease (ASSET 1)

Last updated: September 15, 2006 at 4:30:37 PM